As CD36 expression in cancer cells drives stem cell-like traits, and promotes drug resistance and metastatic potential of CSCs [17,59,62,64], PKD1-mediated CD36 expression might also play an important role in metastatic progression of pNETs, very likely via CD36-mediated fatty acid metabolism [62]. Here, PKD1 is linked to cancer.